Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Am Heart J. 2014 Feb 17;167(5):735–742.e2. doi: 10.1016/j.ahj.2014.02.003

Table II. Predictors of first all-cause hospitalization.

Adjusted HR
(95% CI)
t Value P
NYHA class III/IV 1.57 (1.38–1.78) 6.80 <.0001
Increased heart rate (>66), per 10 beats/min 1.11 (1.07–1.16) 5.36 <.0001
NYHA class II 1.35 (1.21–1.51) 5.28 <.0001
EHRA severe 1.37 (1.21–1.55) 5.09 <.0001
COPD 1.23 (1.12–1.34) 4.37 <.0001
Prior treatment with antiarrhythmic drug 1.16 (1.07–1.27) 3.62 .0003
Prior MI 1.17 (1.07–1.29) 3.28 .001
Peripheral vascular disease 1.18 (1.07–1.31) 3.31 .0009
History of PCI 1.18 (1.07–1.30) 3.34 .0008
Diabetes 1.13 (1.05–1.22) 3.22 .001
NYHA class I 1.21 (1.07–1.36) 3.13 .002
EHRA mild 1.16 (1.06–1.28) 3.22 .001
Not living independently 1.24 (1.09–1.42) 3.29 .001
Obstructive sleep apnea 1.16 (1.05–1.28) 2.94 .003
Severe LAE 1.21 (1.07–1.36) 3.03 .003
Anemia 1.15 (1.05–1.26) 2.95 .003
Hypothyroidism 1.11 (1.03–1.20) 2.77 .006
Cancer 1.12 (1.03–1.21) 2.70 .007
Frailty 1.20 (1.05–1.39) 2.61 .009
Moderate LAE 1.11 (0.99–1.25) 1.73 .08
Mild LAE 1.07 (0.94–1.20) 1.02 .3
EHRA disabling symptoms 1.06 (0.78–1.45) 0.39 .7
Increased heart rate (≤66), per 10 beats/min 0.89 (0.80–0.99) −2.07 .04
Increased diastolic blood pressure, per 10 mm Hg 0.95 (0.91–0.99) −2.42 .02
Increased hematocrit, per 10% 0.83 (0.76–0.90) −4.40 <.0001

c Index = 0.63.

Abbreviations: COPD, chronic obstructive lung disease; PCI, percutaneous coronary intervention; CHF, congestive heart failure; LAE, left atrial enlargement.